Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 190 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission

Giant Cell Arteritis Phase 3 Germany

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

Hypercholesterolemia Germany

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

Coronary Artery Disease Phase 3 United States
Spain
Belgium
Australia
India
China
United Kingdom
Hungary
Argentina
Korea, Republic of
Brazil
Ireland
Switzerland
Japan
Italy
Canada
France
Chile
View All

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Nonsmall Cell Lung Cancer, Colorectal Cancer, Colorectal Carcinoma, Colorectal Neoplasms, Colorectal Tumors, Neoplasms, Colorectal Phase 1, Phase 2 United States
Spain
France
Germany
Belgium
Italy
Korea, Republic of
Singapore
View All

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

Sjogren Syndrome Phase 3 United States
Turkey
Czech Republic
Poland
Mexico
Belgium
Austria
Guatemala
Brazil
China
France
Chile
Korea, Republic of
Spain
Lithuania
View All

Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

Sjogren Syndrome Phase 3 United States
India
Colombia
Lebanon
Brazil
Argentina
Chile
Mexico
United Kingdom
Germany
Israel
China
Australia
South Africa
Canada
Italy
View All

A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis

Relapsing Multiple Sclerosis Germany

Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials

Spinal Muscular Atrophy (SMA) Phase 3 United States
Spain
Denmark
France
Taiwan
Japan
Belgium
United Kingdom
Canada
Australia
Italy
Singapore
View All

A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.

Small Cell Lung Carcinoma Phase 1 United States

Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity

Retinopathy of Prematurity Korea, Republic of